BCRX earnings call for the period ending September 30, 2021.
Compare BCRX Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: BioCryst Pharmaceuticals
The biotech's third quarter was a good one, once you look past the top-line numbers.
These two small drugmakers are poised for a long-winded growth spurt.
BCRX earnings call for the period ending June 30, 2021.
The company's first commercial drug launch keeps exceeding expectations.
There's more than one opportunity for it to do so.
This commercial-stage drugmaker trades for less than many of its clinical-stage peers.
Shares of these biotechs have been soaring in the opposite direction of their peers.
Investors appear to be increasingly optimistic about the outlook for its drug Orladeyo.
BCRX earnings call for the period ending March 31, 2021.